Upgrade to SI Premium - Free Trial

Biogen Idec, Inc. (BIIB) Tops Q3 EPS Views; Boosts FY13 Outlook

October 28, 2013 7:16 AM
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $2.35, $0.25 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Earnings Hot Guidance Hot List

Next Articles